Gene · 3587
Papers3,503
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,503
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review. | Nutrients | 2022 | 35745251 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell Mechanisms of Action and Clinical Effects in Osteoarthritis: A Narrative Review. | Genes (Basel) | 2022 | 35741711 | PubTator, text mining | PubMed |
| IL-10 Gene Polymorphisms and IL-10 Serum Levels in Patients with Multiple Sclerosis in Lithuania. | Brain Sci | 2022 | 35741685 | PubTator, text mining | PubMed |
| Regulation of the Intestinal Extra-Adrenal Steroidogenic Pathway Component LRH-1 by Glucocorticoids in Ulcerative Colitis. | Cells | 2022 | 35741034 | PubTator, text mining | PubMed |
| Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells. | Biomolecules | 2022 | 35740975 | PubTator, text mining | PubMed |
| Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC. | Cancers (Basel) | 2022 | 35740564 | PubTator, text mining | PubMed |
| Bioinformatics-Led Discovery of Osteoarthritis Biomarkers and Inflammatory Infiltrates. | Front Immunol | 2022 | 35734177 | PubTator, text mining | PubMed |
| Macrophages derived from pluripotent stem cells: prospective applications and research gaps. | Cell Biosci | 2022 | 35725499 | PubTator, text mining | PubMed |
| The Role of Crosstalk of Immune Cells in Pathogenesis of Chronic Spontaneous Urticaria. | Front Immunol | 2022 | 35711438 | PubTator, text mining | PubMed |
| The balance between protective and pathogenic immune responses to pneumonia in the neonatal lung is enforced by gut microbiota. | Sci Transl Med | 2022 | 35704600 | PubTator, text mining | PubMed |
| CXCL4 synergizes with TLR8 for TBK1-IRF5 activation, epigenomic remodeling and inflammatory response in human monocytes. | Nat Commun | 2022 | 35701499 | PubTator, text mining | PubMed |
| Prognostic and tumor immunity implication of inflammatory bowel disease-associated genes in colorectal cancer. | Eur J Med Res | 2022 | 35698180 | PubTator, text mining | PubMed |
| mirTarRnaSeq: An R/Bioconductor Statistical Package for miRNA-mRNA Target Identification and Interaction Analysis. | BMC Genomics | 2022 | 35698050 | PubTator, text mining | PubMed |
| Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study. | Intest Res | 2022 | 35686293 | PubTator, text mining | PubMed |
| Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components. | Int J Mol Sci | 2022 | 35682890 | PubTator, text mining | PubMed |
| Recent Advances in Host-Directed Therapies for Tuberculosis and Malaria. | Front Cell Infect Microbiol | 2022 | 35669122 | PubTator, text mining | PubMed |
| Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis. | Nat Commun | 2022 | 35660734 | PubTator, text mining | PubMed |
| Challenges and opportunities targeting mechanisms of epithelial injury and recovery in acute intestinal graft-versus-host disease. | Mucosal Immunol | 2022 | 35654837 | PubTator, text mining | PubMed |
| LKB1: Can We Target an Hidden Target? Focus on NSCLC. | Front Oncol | 2022 | 35646638 | PubTator, text mining | PubMed |
| The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives. | Front Cell Neurosci | 2022 | 35634470 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3587/papers?page=37